Floatz logo

RAMIFENTANYL

Sternotomy

St. Antonius HospitalSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Sternotomy cohort.

Asset / SponsorPhaseRating
MIVACURIUM ION
St. Antonius Hospital
Phase 4BB
PROPOFOL
St. Antonius Hospital
Phase 4BB
FENTANYL
St. Antonius Hospital
Phase 4BB
ROPIVACAINE
University of British Columbia
Phase 2/3BB

Same molecule, other indications

RAMIFENTANYL is also rated in:

morbid obesityDormant
BBB
Indicative ·
73 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
73 / 100
View asset →
Anesthesia, GeneralDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →